Commentary on: "Comprehensive transcriptional analysis of early-stage urothelial carcinoma." Hedegaard J, Lamy P, Nordentoft I, Algaba F, Høyer S, Ulhøi BP, Vang S, Reinert T, Hermann GG, Mogensen K, Thomsen MB, Nielsen MM, Marquez M, Segersten U, Aine M, Höglund M, Birkenkamp-Demtröder K, Fristrup N, Borre M, Hartmann A, Stöhr R, Wach S, Keck B, Seitz AK, Nawroth R, Maurer T, Tulic C, Simic T, Junker K, Horstmann M, Harving N, Petersen AC, Calle ML, Steyerberg EW, Beukers W, van Kessel KE, Jensen JB, Pedersen JS, Malmström PU, Malats N, Real FX, Zwarthoff EC, Ørntoft TF, Dyrskjøt L. Cancer Cell. 2016 Jul 11;30(1):27-42.

Autor: Lee BH

Publikováno v: Urologic oncology [Urol Oncol] 2017 Sep; Vol. 35 (9), pp. 576-577. Date of Electronic Publication: 2017 Aug 05.

Bladder cancer detection in urine by novel methylation markers.

Autor: Beijert, Irene J.^1,2,3 (AUTHOR) i.j.beijert@amsterdamumc.nl, Wever, Birgit M. M.^2,3,4,5 (AUTHOR), Hentschel, Anouk E.¹ (AUTHOR), van den Burgt, Yara^2,3 (AUTHOR), Kauer, Paul C.⁶ (AUTHOR), Lissenberg-Witte, Birgit I.⁷ (AUTHOR), van Moorselaar, R. Jeroen A.¹ (AUTHOR), Steenbergen, Renske D. M.^2,3 (AUTHOR), Nieuwenhuijzen, Jakko A.¹ (AUTHOR)

Publikováno v: Scientific Reports. 11/20/2024, Vol. 14 Issue 1, p1-11. 11p.

380 - Prognostic impact of a 12-gene progression score in non-muscle invasive bladder cancer: A prospective multicenter validation study

Autor: Dyrskjøt, L., Reinert, T., Algaba, F., Christensen, E., Nieboer, D., Hermann, G., Morgensen, K., Marquez, M., Segersten, U., Hoyer, S., Ulhøj, B., Hartmann, A., Stöhr, R., Wach, S., Nawroth, R., Beukers, W., Schwamborn, K., Tulic, C., Simic, T., Junker, K., Harving, N., Petersen, A.C., Jensen, J.B., Keck, B., Horstmann, M., Maurer, T., Steyerberg, E., Zwarthoff, E., Real, F., Malats, N., Malmström, P.-U., Ørntoft, T.F.

Publikováno v: In European Urology Supplements March 2017 16(3):e669-e670

Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups.

Autor: van Kessel KEM; Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands.; Department of Urology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands., van der Keur KA; Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands., Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Algaba F; Section of Pathology, Fundacio Puigvert, Universitat Autónoma de Barcelona, Barcelona, Spain., Welvaart NYC; Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands., Beukers W; Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands., Segersten U; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Keck B; Department of Urology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany., Maurer T; Department of Urology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany., Simic T; Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Belgrade, Serbia., Horstmann M; Department of Urology, Friedrich-Schiller-University Jena, Jena, Germany., Grimm MO; Department of Urology, Friedrich-Schiller-University Jena, Jena, Germany., Hermann GG; Department of Urology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark., Mogensen K; Department of Urology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark., Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich Alexander-University Erlangen-Nürnberg, Erlangen, Germany., Harving N; Department of Urology, Aalborg University Hospital, Aalborg, Denmark., Petersen AC; Department of Pathology, Aalborg University Hospital, Aalborg, Denmark., Jensen JB; Department of Urology, Aarhus University Hospital, Aarhus, Denmark., Junker K; Department of Urology, Saarland University, Homburg, Germany., Boormans JL; Department of Urology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands., Real FX; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO), Madrid, CIBERONC, Spain.; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain., Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, CIBERONC, Spain., Malmström PU; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Ørntoft TF; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Zwarthoff EC; Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands. e.zwarthoff@erasmusmc.nl.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Apr 01; Vol. 24 (7), pp. 1586-1593. Date of Electronic Publication: 2018 Jan 24.

Advances in Liquid Biopsy for Diagnosis of Bladder Cancer.

Autor: Seok, Jaekwon¹ (AUTHOR), Kwak, Yeonjoo¹ (AUTHOR), Kim, Sewhan² (AUTHOR), Kim, Eun-Mee³ (AUTHOR) esther96@kornu.ac.kr, Kim, Aram^4,5 (AUTHOR) arkim@kuh.ac.kr

Publikováno v: International Neurourology Journal. Jun2024, Vol. 28 Issue 2, p83-95. 13p.